This is a StreetInsider.com Premium Only Page

(BNTX) –

Apr 9, 2024 11:26 AM Moderna jumps as vaccine shows benefit in head and neck cancer in early study

Apr 9, 2024 11:25 AM BMO on BioNTech (BNTX): 'Cancer Vaccine Updates at AACR Incrementally Positive in Our View'

Apr 8, 2024 05:06 PM Form 6-K BioNTech SE For: Apr 08

Apr 8, 2024 07:13 AM Form 6-K BioNTech SE For: Apr 08

Mar 27, 2024 08:46 AM BioNTech (BNTX) PT Lowered to $101 at UBS

Mar 26, 2024 09:53 AM WuXi Biologics Reports Solid 2023 Annual Results

Mar 25, 2024 11:38 AM Midday movers: Apple, Intel, United Airlines fall; Micron rises

Mar 25, 2024 07:28 AM BioNTech gets US agency notice over default on COVID vaccine royalties

Mar 25, 2024 06:00 AM Form 6-K BioNTech SE For: Mar 22

Mar 22, 2024 08:54 AM BioNTech (BNTX) PT Lowered to $90 at HSBC, 'near-term COVID-19 revenue still remains a risk overhang'

Mar 22, 2024 07:31 AM BioNTech (BNTX) PT Lowered to $90 at JPMorgan

Mar 21, 2024 10:29 AM BioNTech (BNTX) PT Lowered to $95 at TD Cowen

Mar 21, 2024 07:29 AM Canaccord Genuity Reviews BioNTech (BNTX) Post Earnings

Mar 21, 2024 06:31 AM BioNTech (BNTX) PT Lowered to $123 at BMO Capital

Mar 21, 2024 04:48 AM BioNTech (BNTX) PT Lowered to $91 at Goldman Sachs

Mar 20, 2024 02:37 PM JPMorgan Continues to See 2024 AS an 'execution year' for BioNTech (BNTX)

Mar 20, 2024 11:26 AM Midday movers: Mobileye, Chipotle rise; Signet, BioNTech fall

Mar 20, 2024 07:58 AM Form 20-F BioNTech SE For: Dec 31

Mar 20, 2024 07:34 AM Form 6-K BioNTech SE For: Mar 20

Mar 20, 2024 07:12 AM Form 6-K BioNTech SE For: Mar 20

Mar 20, 2024 07:09 AM Moderna (MRNA) Trades Lower in Sympathy with BioNTech (BNTX)

Mar 20, 2024 06:19 AM BioNTech SE (BNTX) Misses Q4 EPS by 46c, Misses on Revenue; Offers FY24 Revenue Guidance

Mar 20, 2024 06:17 AM After earnings plunge, BioNTech pins hopes on cancer drug launches

Mar 20, 2024 06:00 AM BioNTech SE (BNTX) Appoints Annemarie Hanekamp as Chief Commercial Officer

Mar 20, 2024 06:00 AM BioNTech Announces Appointment of Annemarie Hanekamp to Management Board as Chief Commercial Officer

Mar 11, 2024 09:04 AM Form 6-K BioNTech SE For: Mar 11

Mar 11, 2024 08:00 AM BIONTECH SE (NASDAQ: BNTX) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against BioNTech SE

Mar 8, 2024 09:00 PM BIONTECH DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against BioNTech SE and Encourages Investors to Contact the Firm

Mar 7, 2024 03:09 PM BNTX DEADLINE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages BioNTech SE Investors to Secure Counsel Before Important March 12 Deadline in Securities Class Action – BNTX

Mar 7, 2024 08:42 AM Form 6-K BioNTech SE For: Mar 07

Mar 7, 2024 07:30 AM DEADLINE ALERT: Bernstein Liebhard LLP Reminds BioNTech SE Investors of Upcoming Deadline

Mar 7, 2024 06:45 AM BioNTech Announces Planned Retirement of Sean Marett

Mar 5, 2024 09:00 PM Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against BioNTech, Mobileye, BioVie, and ADM and Encourages Investors to Contact the Firm

Mar 4, 2024 07:30 AM BIONTECH SE (NASDAQ: BNTX) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against BioNTech SE

Mar 3, 2024 03:14 PM BNTX DEADLINE: ROSEN, A TOP RANKED LAW FIRM, Encourages BioNTech SE Investors to Secure Counsel Before Important March 12 Deadline in Securities Class Action – BNTX

Mar 1, 2024 09:00 PM Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against BioNTech, Mobileye, BioVie, and ADM and Encourages Investors to Contact the Firm

Feb 28, 2024 06:26 PM Form 144 BioNTech SE Filed by: ATHOS KG

Feb 28, 2024 05:58 AM BioNTech (BNTX) PT Lowered to $100 at Goldman Sachs

Feb 27, 2024 07:49 PM BNTX DEADLINE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages BioNTech SE Investors to Secure Counsel Before Important March 12 Deadline in Securities Class Action – BNTX

Feb 26, 2024 09:00 PM Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against BioNTech, Mobileye, BioVie, and ADM and Encourages Investors to Contact the Firm

Feb 26, 2024 04:00 PM BIONTECH SE (NASDAQ: BNTX) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against BioNTech SE

Feb 23, 2024 01:00 PM BIONTECH SHAREHOLDER NOTICE: Faruqi & Faruqi Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In BioNTech To Contact Him Directly To Discus

Feb 23, 2024 05:05 AM BMO Capital Starts BioNTech (BNTX) at Outperform, 'COVID Concerns Overshadow an Undervalued Pipeline'

Feb 22, 2024 09:00 PM Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against BioNTech, Mobileye, BioVie, and ADM and Encourages Investors to Contact the Firm

Feb 20, 2024 08:00 AM BIONTECH SE (NASDAQ: BNTX) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against BioNTech SE

Feb 20, 2024 07:18 AM BioNTech (BNTX) PT Raised to $171 at Canaccord Genuity

Feb 18, 2024 09:00 PM Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against BioNTech, Mobileye, BioVie, and ADM and Encourages Investors to Contact the Firm

Feb 16, 2024 05:03 PM ROSEN, SKILLED INVESTOR COUNSEL, Encourages BioNTech SE Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – BNTX

Feb 15, 2024 04:11 PM Form S-8 BioNTech SE

Feb 15, 2024 11:00 AM BIONTECH INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In BioNTech To Contact Him Di